Shakir Atoyebi

7PUBLICATIONS
24CO-AUTHORS
Pharmaceutical delivery technologiesPsychosocial aspects of childbirth and perinatal mental healthEpidemiological modellingFoetal development and medicinePharmacogenomics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Sep 23, 2026
Modelling the tail-phase pharmacokinetics of long-acting cabotegravir and rilpivirine from early pregnancy to postpartum at steady state.

|Feb 02, 2026
Advancing Maternal Health with Long-Acting Therapeutics: Priorities, Efficacy and Safety Considerations, and Emerging Technologies.

Rachel K Scott, Sharon Nachman, Ethel D Weld

|Feb 01, 2026
PKRxiv: A Best Practice Model for Advancing Pharmacoequity Through Open Pharmacokinetic Data Sharing.

Shakir Atoyebi, Prajith Venkatasubramanian, Abdulafeez Akinloye

|Aug 12, 2025
Model-based evaluation of the interaction between ritonavir-boosted atazanavir and rifampicin in Ugandan adults with HIV.

Allan Kengo, Juan Eduardo Resendiz-Galvan, Letisha Najjemba

|Nov 09, 2024
Physiologically based pharmacokinetic modeling of drug-drug interactions between ritonavir-boosted atazanavir and rifampicin in pregnancy.

Shakir Atoyebi, Maiara Camotti Montanha, Ritah Nakijoba

|Feb 10, 2024
Physiologically-based pharmacokinetic modelling of long-acting injectable cabotegravir and rilpivirine in pregnancy.

Shakir Atoyebi, Fazila Bunglawala, Nicolas Cottura

Pageof 2

Frequent Collaborators

4 joint publications

Adeniyi Olagunju

4 joint publications

Catriona Waitt

2 joint publications

Oluwasegun Eniayewu

2 joint publications

Paolo Denti